P
Preetham Kumar
Researcher at University of California, Los Angeles
Publications - 30
Citations - 313
Preetham Kumar is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Medicine & Patent foramen ovale. The author has an hindex of 5, co-authored 18 publications receiving 190 citations.
Papers
More filters
Journal ArticleDOI
Functional analysis of microRNAs in human hepatocellular cancer stem cells
Fanyin Meng,Shannon Glaser,Heather Francis,Sharon DeMorrow,Yuyan Han,Jenna Passarini,Allison Stokes,John P. Cleary,Xiuping Liu,Julie Venter,Preetham Kumar,Sally Priester,Levi Hubble,Dustin Staloch,Jay Sharma,Chang-Gong Liu,Gianfranco Alpini,Gianfranco Alpini +17 more
TL;DR: In this paper, the expression of microRNAs in hepatocellular cancer stem cells (HSCs) was evaluated by microarray profiling, and defined the target genes and functional effects of two groups of microRNA regulated by IL-6 and transcriptional factor Twist.
Journal ArticleDOI
Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke.
Akram Y. Elgendy,Jeffrey L. Saver,Zahid Amin,Konstantinos Dean Boudoulas,John D. Carroll,Islam Y. Elgendy,Iris Q. Grunwald,Zachary M. Gertz,Ziyad M. Hijazi,Eric Horlick,Scott E. Kasner,David M. Kent,Preetham Kumar,Clifford J. Kavinsky,David S Liebeskind,Helmi L. Lutsep,Mohammad K. Mojadidi,Steven R. Messé,Jean-Louis Mas,Heinrich Mattle,Bernhard Meier,Ahmad Mahmoud,Ahmed N. Mahmoud,Fabian Nietlispach,Nimesh K. Patel,John F. Rhodes,Mark Reisman,Robert J. Sommer,Horst Sievert,Lars Søndergaard,Muhammad Zaman,David E. Thaler,Jonathan M. Tobis +32 more
TL;DR: A revised general nomenclature and classification framework for PFO-associated stroke is proposed and detailed revisions for the 3 major stroke subtyping algorithms in wide use are proposed.
Journal ArticleDOI
The Connection Between Patent Foramen Ovale and Migraine.
TL;DR: Although PFO closure is currently not a FDA-approved therapy for migraines, randomized trials suggest that this intervention may benefit a subgroup of migraineurs.
Journal ArticleDOI
Comparison of Residual Shunt Rate and Complications across 6 Different Closure Devices for Patent Foramen Ovale
Rubine Gevorgyan Fleming,Preetham Kumar,Brian H. West,Nabil Noureddin,Joshua Rusheen,Jamil Aboulhosn,Jonathan M. Tobis +6 more
TL;DR: To compare residual shunt rate and complications associated with six different devices used for PFO closure, researchers used a database of more than 1,000 PFO patients from around the world to select six to study.
Journal ArticleDOI
Pooled Analysis of PFO Occluder Device Trials in Patients With PFO and Migraine.
Mohammad K. Mojadidi,Preetham Kumar,Ahmed N. Mahmoud,Islam Y. Elgendy,Hilary Shapiro,Brian L. West,Andrew Charles,Heinrich Mattle,Sherman G. Sorensen,Bernhard Meier,Stephen D. Silberstein,Jonathan M. Tobis +11 more
TL;DR: A pooled analysis of patient-level data demonstrates that PFO closure was safe and significantly reduced the mean number of monthly migraine days and monthly migraine attacks, and resulted in a greater number of patients who experienced complete migraine cessation as mentioned in this paper.